BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 24670451)

  • 1. [Screening of novel miRNAs targeting EZH2 3' untranslated region using lentivirus miRNAs library and their expressions in breast cancer cells and tissues].
    Liu C; Wang L; Zhao W; Peng Y; Wang Y; Sun Z; Feng J
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Mar; 34(3):368-72. PubMed ID: 24670451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
    Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
    J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
    Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ
    J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-214 provokes cardiac hypertrophy via repression of EZH2.
    Yang T; Zhang GF; Chen XF; Gu HH; Fu SZ; Xu HF; Feng Q; Ni YM
    Biochem Biophys Res Commun; 2013 Jul; 436(4):578-84. PubMed ID: 23727574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNA expression patterns in chemoresistant breast cancer tissues.
    Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
    Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.
    Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ
    Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of novel microRNA candidates from deep sequencing.
    Wu Q; Wang C; Guo L; Ge Q; Lu Z
    Clin Chim Acta; 2013 Jan; 415():239-44. PubMed ID: 23153516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin.
    Li CH; To KF; Tong JH; Xiao Z; Xia T; Lai PB; Chow SC; Zhu YX; Chan SL; Marquez VE; Chen Y
    Gastroenterology; 2013 May; 144(5):1086-1097.e9. PubMed ID: 23395645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
    Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
    Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-101, downregulated in retinoblastoma, functions as a tumor suppressor in human retinoblastoma cells by targeting EZH2.
    Lei Q; Shen F; Wu J; Zhang W; Wang J; Zhang L
    Oncol Rep; 2014 Jul; 32(1):261-9. PubMed ID: 24807198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling.
    Guo Y; Ying L; Tian Y; Yang P; Zhu Y; Wang Z; Qiu F; Lin J
    FEBS J; 2013 Sep; 280(18):4531-8. PubMed ID: 23815091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y; Xu K; Yagüe E
    Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of serum genome-wide microRNAs for breast cancer detection.
    Wu Q; Wang C; Lu Z; Guo L; Ge Q
    Clin Chim Acta; 2012 Jul; 413(13-14):1058-65. PubMed ID: 22387599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of microRNA-26a is associated with metastatic potential and the poor prognosis of osteosarcoma patients.
    Song QC; Shi ZB; Zhang YT; Ji L; Wang KZ; Duan DP; Dang XQ
    Oncol Rep; 2014 Mar; 31(3):1263-70. PubMed ID: 24452597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide mRNA and miRNA expression profiling reveal multiple regulatory networks in colorectal cancer.
    Vishnubalaji R; Hamam R; Abdulla MH; Mohammed MA; Kassem M; Al-Obeed O; Aldahmash A; Alajez NM
    Cell Death Dis; 2015 Jan; 6(1):e1614. PubMed ID: 25611389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-574-3p, identified by microRNA library-based functional screening, modulates tamoxifen response in breast cancer.
    Ujihira T; Ikeda K; Suzuki T; Yamaga R; Sato W; Horie-Inoue K; Shigekawa T; Osaki A; Saeki T; Okamoto K; Takeda S; Inoue S
    Sci Rep; 2015 Jan; 5():7641. PubMed ID: 25560734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased microRNA-214 levels in breast cancer cells coincides with increased cell proliferation, invasion and accumulation of the Polycomb Ezh2 methyltransferase.
    Derfoul A; Juan AH; Difilippantonio MJ; Palanisamy N; Ried T; Sartorelli V
    Carcinogenesis; 2011 Nov; 32(11):1607-14. PubMed ID: 21828058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-101 inhibits melanoma cell invasion and proliferation by targeting MITF and EZH2.
    Luo C; Merz PR; Chen Y; Dickes E; Pscherer A; Schadendorf D; Eichmüller SB
    Cancer Lett; 2013 Dec; 341(2):240-7. PubMed ID: 23962556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinogenesis of intraductal papillary mucinous neoplasm of the pancreas: loss of microRNA-101 promotes overexpression of histone methyltransferase EZH2.
    Nakahara O; Takamori H; Iwatsuki M; Baba Y; Sakamoto Y; Tanaka H; Chikamoto A; Horino K; Beppu T; Kanemitsu K; Honda Y; Iyama K; Baba H
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S565-71. PubMed ID: 21932133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating the epi-miRNome: identification of epi-miRNAs using transfection experiments.
    Reale E; Taverna D; Cantini L; Martignetti L; Osella M; De Pittà C; Virga F; Orso F; Caselle M
    Epigenomics; 2019 Nov; 11(14):1581-1599. PubMed ID: 31693439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.